Compare TKLF & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TKLF | MBAI |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | Japan | Israel |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 8.8M |
| IPO Year | 2020 | 2014 |
| Metric | TKLF | MBAI |
|---|---|---|
| Price | $1.81 | $1.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.5K | ★ 52.2K |
| Earning Date | 12-19-2025 | 05-12-2026 |
| Dividend Yield | ★ 10.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $0.95 |
| 52 Week High | $4.32 | $3.92 |
| Indicator | TKLF | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 55.81 |
| Support Level | $1.78 | $0.99 |
| Resistance Level | $2.43 | $1.83 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 37.44 | 60.69 |
Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.